
    
      Patients with TON will be visited. After being eligible to enter the study and obtaining
      informed consent, they will be randomly assigned into 3 groups of different total dose of
      intravenous administration of EPO to which patients and outcome assessors will be masked.
      They will be assessed at different follow up time periods with the last follow up of at least
      3 months.
    
  